trans-2-(3-(benzyloxy)phenyl)cyclopropane-1-carboxylic acid
92%
- Product Code: 106631
Molecular Weight: | 268.31 g./mol | Molecular Formula: | C₁₇H₁₆O₃ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of biologically active molecules, particularly those targeting neurological and inflammatory disorders. Its structure, featuring a cyclopropane ring and a benzyloxy group, makes it a valuable building block for developing compounds with potential therapeutic effects. Researchers often modify its structure to enhance drug-like properties, such as bioavailability and target specificity. It is also explored in the development of enzyme inhibitors and receptor modulators, contributing to the advancement of treatments for complex diseases.
Product Specification:
Test | Specification |
---|---|
Appearance | White Solid |
Purity (%) | 91.5-100 |
Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.500 | 10-20 days | £429.72 |
+
-
|
1.000 | 10-20 days | £565.43 |
+
-
|
5.000 | 10-20 days | £1,899.83 |
+
-
|
trans-2-(3-(benzyloxy)phenyl)cyclopropane-1-carboxylic acid
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of biologically active molecules, particularly those targeting neurological and inflammatory disorders. Its structure, featuring a cyclopropane ring and a benzyloxy group, makes it a valuable building block for developing compounds with potential therapeutic effects. Researchers often modify its structure to enhance drug-like properties, such as bioavailability and target specificity. It is also explored in the development of enzyme inhibitors and receptor modulators, contributing to the advancement of treatments for complex diseases.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :